Authors: Monahan, JB Hood, WF Welply, JK Shieh, JJJ Polazzi, JO Li, X

Citation: Jb. Monahan et al., Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors, EXP HEMATOL, 29(4), 2001, pp. 416-424

Authors: Streeter, PR Minster, NI Kahn, LE Hood, WF Vickery, LE Thurman, TL Monahan, JB Welply, JK McKearn, JP Woulfe, SL

Citation: Pr. Streeter et al., Progenipoietins: Biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor, EXP HEMATOL, 29(1), 2001, pp. 41-50

Authors: Hood, WF Feng, YQG Schilling, RJ Gokarn, Y Jarvis, C Remsen, EE Shieh, JJJ Joy, W Klein, BK Polazzi, JO Welply, JK McKearn, JP Monahan, JB

Citation: Wf. Hood et al., Modulation of the binding affinity of myelopoietins for the interleukin-3 receptor by the granulocyte colony-stimulating factor receptor agonist, BIOCHEM, 40(45), 2001, pp. 13598-13606

Authors: Klein, BK Shieh, JJ Grabbe, E Li, X Welply, JK McKearn, JP

Citation: Bk. Klein et al., Receptor binding kinetics of human IL-3 variants with altered proliferative activity, BIOC BIOP R, 288(5), 2001, pp. 1244-1249

Authors: Klein, BK Olins, PO Bauer, SC Caparon, MH Easton, AM Braford, SR Abrams, MA Klover, JA Paik, K Thomas, JW Hood, WF Shieh, JJ Polazzi, JO Donnelly, AM Zeng, DL Welply, JK McKearn, JP

Citation: Bk. Klein et al., Use of combinatorial mutagenesis to select for multiply substituted human interleukin-3 variants with improved pharmacologic properties, EXP HEMATOL, 27(12), 1999, pp. 1746-1756